Arca Biopharma Inc.





After Hours:




Please Login or Register

Login|Register FREE

Stock Price
Open: 0.59
Prev. Close: 0.57
Low/Hi: 0.56 - 0.66
52-Week: 0.45 - 2.71
Equity: 1,961,612
90-Day Avg: 978,839
Todays Stock Vol: 142.6
20-Day (HV): 108.7
52-Week (HV): 99.3
Div. Yield:
Earnings: 7-Aug (Est.)
P/E Ratio:
Market Cap: 7.9 M
Short Int Pct: 0.0%
Pct Held By Inst.: 46.3%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ABIO

ARCA biopharma, Inc is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. The company's lead product candidate, Gencaroâ„¢ (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that is in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and left ventricular systolic dysfunction, or HFREF.
Primary Exchange: NASDAQ
SIC In Vitro & In Vivo Diagnostic Substances
NAICS In-Vitro Diagnostic Substance Manufacturing

ABIO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 13.8 B 1.37811E+10 3,460 3460 0.0% 0 493 493
VXF Vanguard Extended Market ETF 5.9 B 5.9E+09 3,259 3259 0.0% 0 2 K 1873

Wait, Before You Leave...

Want to Know More About ABIO Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon